[HTML][HTML] Updating a clinical Knowledge-Based Planning prediction model for prostate radiotherapy

A Scaggion, M Fusella, S Cavinato, F Dusi… - Physica Medica, 2023 - Elsevier
Background and purpose Clinical knowledge-based planning (KBP) models dedicated to
prostate radiotherapy treatment may require periodical updates to remain relevant and to …

[HTML][HTML] Rectum-spacer related acute toxicity–endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers

A Schörghofer, M Drerup, T Kunit, L Lusuardi… - Radiation …, 2019 - Springer
Background Rectal spacers are used to limit dose to the anterior rectal wall in high dose
external beam radiation therapy of the prostate and have been shown to reduce radiation …

Long‐term clinical outcomes after 12‐fractionated carbon‐ion radiotherapy for localized prostate cancer

H Sato, G Kasuya, H Ishikawa, A Nomoto… - Cancer …, 2021 - Wiley Online Library
There are no clinical reports of long‐term follow‐up after carbon‐ion radiotherapy (CIRT)
using a dose of 51.6 Gy (relative biological effectiveness [RBE]) in 12 fractions for localized …

Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care

SC Kamran, JO Light, JA Efstathiou - Prostate cancer and prostatic …, 2019 - nature.com
Background Advances in radiation technology have transformed treatment options for
patients with localized prostate cancer. The evolution of three-dimensional conformal …

[HTML][HTML] Early outcomes of preoperative 5-fraction radiation therapy for soft tissue sarcoma followed by immediate surgical resection

S Parsai, J Lawrenz, S Kilpatrick, B Rubin… - Advances in Radiation …, 2020 - Elsevier
Purpose There are limited data regarding the use of hypofractionated radiation therapy (RT)
for soft tissue sarcoma. We report early oncologic outcomes and wound complications of …

Ten-year update of a randomized, prospective trial of conventional fractionated versus moderate hypofractionated radiation therapy for localized prostate cancer

V Avkshtol, KJ Ruth, EA Ross, MA Hallman… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE The previously published single institution randomized prospective trial failed to
show superiority in the 5-year biochemical and/or clinical disease failure (BCDF) rate with …

[HTML][HTML] Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial

V Borzillo, E Scipilliti, D Pezzulla, M Serra… - Frontiers in …, 2023 - frontiersin.org
Simple summary Stereotactic body radiotherapy (SBRT) of 35–36.25 Gy in five fractions with
the CyberKnife System yields excellent control with low toxicity in low–intermediate-risk …

[HTML][HTML] Intrafraction prostate motion management during dose-escalated linac-based stereotactic body radiation therapy

D Panizza, V Faccenda, R Lucchini, MC Daniotti… - Frontiers in …, 2022 - frontiersin.org
Background Extreme hypofractionation requires tight planning margins, high dose gradients,
and strict adherence to planning criteria in terms of patient positioning and organ motion …

[HTML][HTML] Estimates of alpha/beta (α/β) ratios for individual late rectal toxicity endpoints: an analysis of the CHHiP trial

DH Brand, SC Brüningk, A Wilkins, K Fernandez… - International Journal of …, 2021 - Elsevier
Purpose Changes in fraction size of external beam radiation therapy exert nonlinear effects
on subsequent toxicity. Commonly described by the linear-quadratic model, fraction size …

The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?

WL Ong, A Loblaw - World Journal of Urology, 2023 - Springer
Purpose Stereotactic body radiotherapy (SBRT) is an emerging treatment option for
localized prostate cancer. There is increasing interest to reduce the number of fractions for …